Literature DB >> 22723502

ROC curve estimation under test-result-dependent sampling.

Xiaofei Wang1, Junling Ma, Stephen L George.   

Abstract

The receiver operating characteristic (ROC) curve is often used to evaluate the performance of a biomarker measured on continuous scale to predict the disease status or a clinical condition. Motivated by the need for novel study designs with better estimation efficiency and reduced study cost, we consider a biased sampling scheme that consists of a SRC and a supplemental TDC. Using this approach, investigators can oversample or undersample subjects falling into certain regions of the biomarker measure, yielding improved precision for the estimation of the ROC curve with a fixed sample size. Test-result-dependent sampling will introduce bias in estimating the predictive accuracy of the biomarker if standard ROC estimation methods are used. In this article, we discuss three approaches for analyzing data of a test-result-dependent structure with a special focus on the empirical likelihood method. We establish asymptotic properties of the empirical likelihood estimators for covariate-specific ROC curves and covariate-independent ROC curves and give their corresponding variance estimators. Simulation studies show that the empirical likelihood method yields good properties and is more efficient than alternative methods. Recommendations on number of regions, cutoff points, and subject allocation is made based on the simulation results. The proposed methods are illustrated with a data example based on an ongoing lung cancer clinical trial.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22723502      PMCID: PMC3577107          DOI: 10.1093/biostatistics/kxs020

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  8 in total

1.  Regression analysis of correlated receiver operating characteristic data.

Authors:  A Toledano; C A Gatsonis
Journal:  Acad Radiol       Date:  1995-03       Impact factor: 3.173

2.  A general regression methodology for ROC curve estimation.

Authors:  A N Tosteson; C B Begg
Journal:  Med Decis Making       Date:  1988 Jul-Sep       Impact factor: 2.583

3.  Assessment of diagnostic tests when disease verification is subject to selection bias.

Authors:  C B Begg; R A Greenes
Journal:  Biometrics       Date:  1983-03       Impact factor: 2.571

4.  Construction of receiver operating characteristic curves when disease verification is subject to selection bias.

Authors:  R Gray; C B Begg; R A Greenes
Journal:  Med Decis Making       Date:  1984       Impact factor: 2.583

5.  A semiparametric empirical likelihood method for biased sampling schemes with auxiliary covariates.

Authors:  Xiaofei Wang; Haibo Zhou
Journal:  Biometrics       Date:  2006-12       Impact factor: 2.571

6.  Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.

Authors:  Martin J Edelman; Dee Watson; Xiaofei Wang; Carl Morrison; Robert A Kratzke; Scott Jewell; Lydia Hodgson; Ann M Mauer; Ajeet Gajra; Gregory A Masters; Michelle Bedor; Everett E Vokes; Mark J Green
Journal:  J Clin Oncol       Date:  2008-02-20       Impact factor: 44.544

7.  A semiparametric empirical likelihood method for data from an outcome-dependent sampling scheme with a continuous outcome.

Authors:  Haibo Zhou; M A Weaver; J Qin; M P Longnecker; M C Wang
Journal:  Biometrics       Date:  2002-06       Impact factor: 2.571

8.  Estimation of AUC or Partial AUC under Test-Result-Dependent Sampling.

Authors:  Xiaofei Wang; Junling Ma; Stephen George; Haibo Zhou
Journal:  Stat Biopharm Res       Date:  2012-10-01       Impact factor: 1.452

  8 in total
  3 in total

1.  On Enrichment Strategies for Biomarker Stratified Clinical Trials.

Authors:  Xiaofei Wang; Jingzhu Zhou; Ting Wang; Stephen L George
Journal:  J Biopharm Stat       Date:  2017-10-30       Impact factor: 1.051

2.  Time-dependent classification accuracy curve under marker-dependent sampling.

Authors:  Zhaoyin Zhu; Xiaofei Wang; Paramita Saha-Chaudhuri; Andrzej S Kosinski; Stephen L George
Journal:  Biom J       Date:  2016-04-27       Impact factor: 2.207

3.  Auxiliary variable-enriched biomarker-stratified design.

Authors:  Ting Wang; Xiaofei Wang; Haibo Zhou; Jianwen Cai; Stephen L George
Journal:  Stat Med       Date:  2018-09-16       Impact factor: 2.373

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.